Intervening to reduce alcohol use is associated with a lower likelihood that an individual will receive a new opioid prescription or develop an opioid use disorder, according to a study led by researchers at Duke University and the Durham Veterans Affairs (VA) Medical Center.

Globally, the need for mental health care far outstrips the number of professionally trained providers. Duke global health researchers and clinicians are helping address that need by training non-specialists to provide mental health support in communities without access to specialized resources.

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

Dr. Klotman shares news about faculty awards, graduation and more.

The Duke University School of Medicine has announced the 2024 Michelle P.

Zhang’s group at Duke is studying the half of the human genome that is made up of long, repetitive sequences of DNA called transposons, or “jumping genes.” They’re given that nickname because of their habit of jumping around in the genome, making changes and enabling evolution.

Dr. Kathleen A. Cooney, Chair of the Duke Department of Medicine (DOM) and renowned medical oncologist, has been elected as the incoming president of the Association of Professors of Medicine (APM).

Study of 107 older adults finds that non-white New York and North Carolina residents with mild cognitive impairment reside in places with more environmental injustices than their white peers.

Duke University School of Medicine is proud to acknowledge the faculty members who were selected as recipients of this year’s School of Medicine faculty awards.

A team of Duke researchers describe a synthetic molecule that mimics the effects of compounds in the saliva of blood-sucking critters that can also be swiftly reversed, enabling clotting to resume when needed after treatment.